Biopharmaceutical Committee
The Biopharmaceutical Committee makes policy recommendations on the development of infrastructure for the promotion of biopharmaceutical R&D. The committee also makes recommendations on technical issues ranging from R&D to production and post-marketing activities. The committee also conducts surveys and research on various technical issues related to biopharmaceuticals, from research and development to production and post-marketing activities, and makes recommendations for improvement to the government and other relevant agencies.
Notices and Updates
-
Biopharmaceutical Committee
Report on "CMC Strategy Forum Japan 2025" is now available.
-
Biopharmaceutical Committee
Report on "BioJapan 2025" is now available.
-
Biopharmaceutical Committee
Report on "JPMA Media Forum" is now available.
-
Biopharmaceutical Committee
The article by Kurata, Chairperson of Biopharmaceuticals Committee, is published in Nikkan Yakugyo.
-
Biopharmaceutical Committee
The report "Analysis of Application Documents for Regenerative Medicine Product Approval (Life Cycle Management Information)" is updated.
Biopharmaceutical Committee Contents
-
Implementation Plan
The implementation plan for this fiscal year is posted.
-
Biopharmaceuticals
The importance and diversity of biopharmaceuticals, which are indispensable and valuable for modern medicine, are explained in an easy-to-understand manner.
-
Biopharmaceutical Committee's Deliverables
Biopharmaceutical Committee's deliverables are posted.
-
Announcement from Biopharmaceutical Committee
Various announcements from Biopharmaceutical Committee are posted.